Kelly L. Close

ORCID: 0000-0001-7332-1380
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Diabetes Management and Education
  • Diabetes and associated disorders
  • Diet and metabolism studies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Metabolism, Diabetes, and Cancer
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Mobile Health and mHealth Applications
  • Pharmacology and Obesity Treatment
  • Dental Health and Care Utilization
  • Natural Antidiabetic Agents Studies
  • Chronic Disease Management Strategies
  • Obesity and Health Practices
  • Pharmaceutical studies and practices
  • Biosimilars and Bioanalytical Methods
  • Iron Metabolism and Disorders
  • Food Security and Health in Diverse Populations
  • Global Public Health Policies and Epidemiology
  • Pharmaceutical Economics and Policy
  • Clinical practice guidelines implementation
  • Emergency and Acute Care Studies
  • Adolescent and Pediatric Healthcare
  • Neurological Disorders and Treatments

Close Concerns (United States)
2015-2024

San Francisco Foundation
2015-2022

University of San Francisco
2020

NC Department of Health and Human Services
2010-2018

Columbia University
2017

Joslin Diabetes Center
2017

American Association of Diabetes Educators
2017

University of Hawaiʻi at Mānoa
2017

Regione Lazio
2016

Agenzia Regionale Parchi
2016

OBJECTIVE This study evaluated the association of time in range (TIR) 70–180 mg/dL (3.9–10 mmol/L) with development or progression retinopathy and microalbuminuria using Diabetes Control Complications Trial (DCCT) data set order to validate use TIR as an outcome measure for clinical trials. RESEARCH DESIGN AND METHODS In DCCT, blood glucose concentrations were measured at a central laboratory from seven fingerstick samples (seven-point testing: pre- 90-min postmeals bedtime) collected during...

10.2337/dc18-1444 article EN Diabetes Care 2018-10-23

Ann M. Carracher, Payal H. Marathe, and Kelly L. Close are of Concerns ( http://www.closeconcerns.com ), a healthcare information company focused exclusively on diabetes obesity care. publishes Closer Look , periodical that brings together news insights in these areas. Each month, the Journal Diabetes includes this News feature, which review latest developments relevant to researchers clinicians.

10.1111/1753-0407.12644 article EN Journal of Diabetes 2018-01-18

While A1C is well established as an important risk marker for diabetes complications, with the increasing use of continuous glucose monitoring (CGM) to help facilitate safe and effective management, it understand how CGM metrics, such mean glucose, correlate. Estimated (eA1C) a measure converting from or self-monitored blood readings, using formula derived readings population individuals, into estimate simultaneously measured laboratory A1C. Many patients clinicians find eA1C be helpful...

10.2337/dc18-1581 article EN Diabetes Care 2018-09-17

Abstract The significant and growing global prevalence of diabetes continues to challenge people with (PwD), healthcare providers, payers. While maintaining near-normal glucose levels has been shown prevent or delay the progression long-term complications diabetes, a proportion PwD are not attaining their glycemic goals. During past 6 years, we have seen tremendous advances in automated insulin delivery (AID) technologies. Numerous randomized controlled trials real-world studies that use AID...

10.1210/endrev/bnac022 article EN cc-by-nc-nd Endocrine Reviews 2022-09-06

IN BRIEF This study quantitatively measures diabetes stigma and its associated psychosocial impact in a large population of U.S. patients with type 1 or 2 using an online survey sent to 12,000 people diabetes. A majority respondents (76%) (52%) reported that comes stigma. Perceptions were significantly higher among than those diabetes, the highest rate parents children (83%) lowest who did not use insulin (49%). Our results suggest disturbingly high percentage experience stigma, particularly...

10.2337/cd16-0020 article EN cc-by-nc-nd Clinical Diabetes 2017-01-01

Language is powerful and can have a strong impact on perceptions as well behavior. A task force, consisting of representatives from the American Association Diabetes Educators (AADE) (ADA), convened to discuss language in diabetes care education. This document represents expert opinion force. The literature supports need for movement There are effective ways communicating about diabetes. article provides recommendations used by health professionals others when discussing through spoken or...

10.2337/dci17-0041 article EN Diabetes Care 2017-10-17
David C. Klonoff Jing Wang David Rodbard Michael A. Kohn Chengdong Li and 89 more Dorian Liepmann David Kerr David Ahn Anne L. Peters Guillermo E. Umpierrez Jane Jeffrie Seley Nicole Y. Xu Kevin T. Nguyen Gregg D. Simonson Michael S. D. Agus Mohammed E. Al‐Sofiani Gustavo Armaiz-Peña Timothy S. Bailey Ananda Basu Tadej Battelino Sewagegn Yeshiwas Pierre‐Yves Benhamou B. Wayne Bequette Thomas Blevins Marc D. Breton Jessica R. Castle J. Geoffrey Chase Kong Y. Chen Pratik Choudhary Mark A. Clements Kelly L. Close Curtiss B. Cook Thomas Danne Francis J. Doyle Angela Drincic Kathleen Dungan Steven V. Edelman Niels Ejskjær Juan Espinoza G. Alexander Fleming Gregory P. Forlenza Guido Freckmann Rodolfo J. Galindo Ana María Gómez Hanna A. Gutow Lutz Heinemann Irl B. Hirsch Thanh D. Hoang Roman Hovorka Johan Jendle Linong Ji Shashank Joshi Michaël Joubert Suneil K. Koliwad Rayhan A. Lal M. Cecilia Lansang Wei-An Lee Lalantha Leelarathna Lawrence A. Leiter Marcus Lind Michelle L. Litchman Julia K. Mader Katherine Mahoney Boris Mankovsky Umesh Masharani Nestoras Mathioudakis Alexander Yur'evich Mayorov Jordan Messler Joshua D. Miller Viswanathan Mohan James H. Nichols Kirsten Nørgaard David N. O’Neal Francisco J. Pasquel Athena Philis‐Tsimikas Thomas R. Pieber Moshe Phillip William H. Polonsky Rodica Pop‐Busui Gerry Rayman Eun‐Jung Rhee Steven Russell Viral N. Shah Jennifer L. Sherr Koji Sode Elias K. Spanakis Deborah J. Wake Kayo Waki Amisha Wallia Melissa E. Weinberg Howard Wolpert Eugene E. Wright Mihail Zilbermint Boris Kovatchev

Background: A composite metric for the quality of glycemia from continuous glucose monitor (CGM) tracings could be useful assisting with basic clinical interpretation CGM data. Methods: We assembled a data set 14-day 225 insulin-treated adults diabetes. Using balanced incomplete block design, 330 clinicians who were highly experienced analysis and ranked best to worst glycemia. used principal component multiple regressions develop model predict clinician ranking based on seven standard...

10.1177/19322968221085273 article EN Journal of Diabetes Science and Technology 2022-03-29

The increasing prevalence of diabetes, combined with a growing global shortage health care professionals (HCP), necessitates the need to develop new approaches diabetes delivery expand access care, lessen burden on people improve efficiencies, and reduce unsustainable financial liability systems payers. Use digital technologies telehealth protocols within digital/virtual clinic has potential address these challenges. However, several issues must be resolved move forward. In February 2020,...

10.1089/dia.2020.0375 article EN Diabetes Technology & Therapeutics 2020-09-09

To frame the substantial prevalence of type 2 diabetes (T2D) as a 'Modern Preventable Pandemic' (MPP) and present certain replicable policy lessons from COVID-19 crisis to address it. A literature review was performed analyze data about T2D pandemics establish their multi-factorial health, social, economic impacts. With global tripling in last two decades, has become an MPP largely due modifiable human behaviors. Certain successful elements response pandemic provide important that can be...

10.1016/j.pmedr.2021.101636 article EN cc-by-nc-nd Preventive Medicine Reports 2021-11-18

IN BRIEF After assessing patient perspectives on the success of current diabetes therapies and factors that have greatest impact daily life, we show time-in-range is a crucial outcome for people with are falling short this metric. We also patients feel significant stress worry, they believe in diet, exercise, weight maintenance. In addition, diet exercise in-range blood glucose biggest drivers improved management mindset. Together, these findings support need improve outcomes including beyond A1C.

10.2337/cd17-0094 article EN cc-by-nc-nd Clinical Diabetes 2017-12-28

Language is powerful and can have a strong impact on perceptions as well behavior. A task force, consisting of representatives from the American Association Diabetes Educators Association, convened to discuss language in diabetes care education. The literature supports need for movement There are effective ways communicating about diabetes. This article provides recommendations used by health professionals others when discussing through spoken or written words, whether directed people with...

10.1177/0145721717735535 article EN The Diabetes Educator 2017-10-17

Abstract Objective We conducted a cluster-randomized controlled trial to assess the efficacy of cereal made from caterpillars, micronutrient-rich, locally available alternative animal-source food, on reducing stunting and anaemia in infants Democratic Republic Congo. Design Six-month-old were cluster randomized receive either caterpillar daily until 18 months age or usual diet. At age, anthropometric measurements biological samples collected. Setting The rural Equateur Province Subjects One...

10.1017/s1368980014003334 article EN Public Health Nutrition 2015-01-29

In Brief There is great enthusiasm for the potential of digital health solutions in medicine and diabetes to address key care challenges: patient provider burden, lack data inform therapeutic decision-making, poor access care, costs. However, field still its nascent days; many patients providers do not currently engage with tools, those who do, burden often high. Over time, has excellent collect more seamlessly, make collected useful, drive better outcomes at lower costs less time. But there...

10.2337/diaclin.34.3.133 article EN cc-by-nc-nd Clinical Diabetes 2016-07-01

IN BRIEF Biosimilar insulins are likely to enter the insulin landscape as patents for major branded products start expire in next few years. have potential reduce diabetes treatment costs, increase accessibility of treatment, and expand number brands available those with diabetes. However, they will overcome numerous regulatory hurdles, meet a variety commercial demands, effectively confront competition from both established next-generation before can succeed on global market.

10.2337/diaclin.30.4.138 article EN Clinical Diabetes 2012-10-01
Coming Soon ...